多重检查点细胞向siRNAs使用抗体导向的脂质聚合物混合纳米粒子
Ritam Das1,2, Jewel Medeiros1,2, Jithu Krishna1,2
1Department of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Bioconjugate chemistry
|July 3, 2025
概括
研究人员开发了新的抗体功能化纳米颗粒,用于针对性地向三阴性乳腺癌等侵袭性癌症输送siRNA. 这种多点检查策略通过准多个受体来提高安全性和有效性,提高纳米药物选择性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 目前的基因疗法在主要器官以外的组织特定向方面扎.
- 被动准方法需要广泛的优化.
- 像抗体-药物合物 (ADC) 这样的积极向策略提供了模块化和有效性.
研究的目的:
- 开发抗体功能化的混合脂质聚合物纳米颗粒,用于向siRNA输送.
- 针对EGFR和TROP2等癌症过度表达的受体,特别是在三阴性乳腺癌 (TNBC) 中.
- 实施多个检查点准策略,采用多个siRNA传递,以提高安全性和有效性.
主要方法:
- 制造具有抗体功能的混合脂质聚合物纳米粒子.
- 针对EGFR和TROP2的抗体的功能化.
- 纳入多个小干扰RNAs (siRNAs) 进行多个检查点准方法.
- 在体外测试使用TNBC细胞模型.
主要成果:
- 证明成功的纳米粒子功能化用于有针对性的交付.
- 在TNBC细胞上对EGFR和TROP2受体的有效向.
- 展示了多个检查点策略的潜力,以提高目标选择性和减少非目标效应.
结论:
- 开发的纳米粒子平台显示了在癌症治疗中稳健和安全的siRNA传递的希望.
- 多重检查点准策略是一种可行的方法,可以提高纳米医学的选择性.
- 这项工作为先进的向癌症治疗奠定了基础,特别是对于像TNBC这样的侵袭性癌症.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


